Market
Scenario:
Malaria is an infectious disease caused
by parasitic protozoa of the Plasmodium type. The symptoms include fever,
fatigue, vomiting, and severe headaches and may lead to seizures, coma, or even
death if untreated. Malaria is primarily a disease of the tropical and
subtropical regions. The carrier of malaria is the female anopheles mosquito
and hence there is a seasonal variation in the cases of malaria. Most cases of
malaria are caused by P. falciparum because other types of plasmodium such as
P. vivax, P. ovale, and P. malariae generally cause a milder form of malaria.
According to World Health Organization (WHO), the
global incidence of malaria between 2010 and 2015, fell by 21% and the malaria
mortality fell by 29%. However the African region carries a disproportionately
high share of the global malaria burden and accounted for 90% of malaria cases
and 92% of malaria deaths worldwide and sub-Saharan Africa accounted for 76% of
malaria cases and 75% deaths globally.
The growth of government programs against malaria
and the support given by international bodies such as WHO is also a market
driver. The market barriers include high cost of imported malaria diagnostic
kits, low penetration of healthcare in Africa, low per capita income, low
number of healthcare professionals in Africa etc. The political causes include
massive corruption, low political power of citizens especially in nondemocratic
nations, civil war in regions such as Malawi etc.
Taking
all factors into consideration, we expect the Africa malaria diagnosis
market to reach around $ 2418.92 million from $ 550 million in 2017, by the end
of the forecast period at a CAGR of ~ 28.0 %. While the malaria treatment
market will grow by a CAGR of 8.1% to reach around $ 7180.7 million from $
4500.0 million in 2016.
Key
Players
·
Alere
Inc.
·
Access
Bio Inc.
·
Premier
Medical Corporation
·
Beckman
Coulter/Danaher
·
bioMerieux
·
Novartis
Diagnostics
·
Siemens
Healthcare
·
Bio-Rad
Laboratories, Cipla Inc.
·
Ipca
Laboratories Ltd.
·
Uni-Med
India
·
Pfizer
Inc.
·
Sun
Pharmaceutical Industries Ltd.
·
Sanofi
Regional
Analysis
The healthcare sector of Africa is
divided between private and state. The public healthcare expenditure accounts
for approximately 48 % of total health expenditure in 2014 with variation in
different countries. Local manufacturing represents a poor outlook which is
limited to consumables and ordinary articles and there are a handful of high
tech devices manufacturers. Africa is extremely dependent on imports for
medical devices and imports account for approximately 90 % of total market for
medical devices and Chinese medical device suppliers dominate the scenario.
Among the regions of Africa, South Africa and Egypt account for 40 % of market.
Other important nations are Nigeria, Morocco and Algeria. Collaboration with
large global companies and technical transfer will remain the key strategy for
developing the regional African market as can be seen by the example of China.
Segments:
Africa
Malaria Diagnosis & Treatment Market has been segmented on the basis of
technique which comprises rapid diagnostic tests (RDT’S), molecular diagnostics
and microscopy. On the basis of malarial parasite; market is segmented into plasmodium falciparum, plasmodium
vivax, plasmodium malariae and plasmodium ovale.
List of Tables
and Figures:
List Of Tables
Table 1
Africa Malaria Diagnosis & Treatment Market, 2013-2022 (Usd Million)
Table 2
Africa Malaria Diagnosis & Treatment Market, By Technique, 2013-2022 (Usd
Million)
Table 3
Africa Malaria Diagnosis & Treatment Market, By Malarial Parasite,
2013-2022 (Usd Million)
Table 4
Africa Malaria Diagnosis & Treatment Market, By Region, 2013-2022 (Usd
Million)
List Of Figures
Figure
1 Research Process
Figure
2 Porters Five Forces Model
Figure
3 Africa Malaria Diagnosis & Treatment Market, By Technique
Figure
4 Africa Malaria Diagnosis & Treatment Market, By Malarial Parasite
Figure
5 Africa Malaria Diagnosis & Treatment Market, By Region
Figure
6 Africa Malaria Diagnosis & Treatment Market: Company Share Analysis, 2015
(%)
...Continued
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment